What is the current Biopsy Guidance Systems market size?

The current market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the Biopsy Guidance Systems market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033.

What are the key drivers of the Biopsy Guidance Systems market?

Increasing cancer incidence and technological advancements are key drivers.

What challenges does the Biopsy Guidance Systems market face?

High costs and limited awareness are significant challenges.

Which regions are leaders in the Biopsy Guidance Systems market?

North America and Europe are current regional leaders.

Who are the top companies in the Biopsy Guidance Systems market?

Major players include GE Healthcare and Siemens Healthineers.

What future opportunities exist in the Biopsy Guidance Systems market?

Emerging markets and innovative technologies offer future opportunities.

How will technology impact the Biopsy Guidance Systems market?

Advances in imaging and robotics will significantly impact the market.

What is the current regulatory landscape for Biopsy Guidance Systems?

Stringent regulations and standards govern the market.

What is the future outlook for the Biopsy Guidance Systems market?

The market is expected to experience significant growth and innovation.

Biopsy Guidance Systems Growth, Trends & Forecast Outlook 2033

Biopsy Guidance Systems by Application (Hospitals, Specialty Clinics, Diagnostic Centers, Research and Academic Institutes, Others), by Types (Stereotactic Guided Biopsy, Ultrasound Guided Biopsy, MRI Guided Biopsy), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 99

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 7.8%

Historical Range: 2020 - 2025

Dec 20, 2025Updated: Jun 8, 2026

Pages: 99

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 7.8%

Historical Range: 2020 - 2025

Loading report content...

Loading report...

Biopsy Guidance Systems Market Size | CAGR 7.8 Forecast 2033

Biopsy Guidance Systems Growth, Trends & Forecast Outlook 2033

🏭 Healthcare🌍 Global

Pages: 99

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 7.8%

Historical Range: 2020 - 2025

Dec 20, 2025Updated: Jun 8, 2026

Pages: 99

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 7.8%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Biopsy Guidance Systems Market Overview

The Biopsy Guidance Systems market refers to the industry that provides medical devices and technologies used to guide biopsy procedures, enabling healthcare professionals to accurately diagnose and treat various diseases. As the demand for minimally invasive procedures continues to rise, the Biopsy Guidance Systems market size is estimated to be around $1.3 billion in 2025. The growth outlook for this market is promising, with a projected market forecast of $2.5 billion by 2033, driven by advancements in technology and an increasing focus on patient care. The industry expansion is expected to be fueled by the rising prevalence of chronic diseases, such as cancer, and the growing need for accurate diagnoses. The scope of this market encompasses various biopsy guidance systems, including ultrasound, magnetic resonance imaging (MRI), and computed tomography (CT) scanners.

Loading chart…

The growth forecast for the Biopsy Guidance Systems market is expected to be driven by a compound annual growth rate (CAGR) of 7.5% from 2026 to 2033. The key forces shaping the industry include technology shifts, such as the development of artificial intelligence (AI) and machine learning (ML) algorithms, regulations, such as those related to medical device safety and efficacy, and consumer behavior, such as the increasing demand for minimally invasive procedures. The largest region in the Biopsy Guidance Systems market is currently North America, while the fastest-growing region is Asia-Pacific. Overall, the Biopsy Guidance Systems market is poised for significant growth, driven by advancements in technology and an increasing focus on patient care.

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.19 billion
Growth rate	CAGR of 7.8% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	BD; Hologic, Inc.; Devicor Medical Products, Inc.; B. Braun Melsungen AG; Boston Scientific Corporation; Planmed Oy
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Biopsy Guidance Systems market is poised for significant growth, driven by technological advancements and increasing demand for minimally invasive procedures. The growth forecast for this market is expected to be substantial, with the global Biopsy Guidance Systems market size anticipated to expand rapidly over the forecast period.

Growth Drivers2 items

Advances in imaging technologies, such as magnetic resonance imaging (MRI) and computed tomography (CT), have improved the accuracy and efficacy of biopsy procedures, driving adoption of Biopsy Guidance Systems.

The rising prevalence of cancer and other diseases that require tissue sampling has increased demand for Biopsy Guidance Systems, contributing to market growth and an expanding Biopsy Guidance Systems market size.

Restraints2 items

High costs associated with Biopsy Guidance Systems, including equipment and maintenance expenses, may limit adoption in resource-constrained healthcare settings, affecting the growth forecast.

Stringent regulatory requirements and the need for specialized training may hinder the widespread adoption of Biopsy Guidance Systems, potentially impacting the Biopsy Guidance Systems market size.

Opportunities2 items

Emerging markets in Asia-Pacific and Latin America offer significant opportunities for Biopsy Guidance Systems manufacturers, driven by growing healthcare infrastructure and increasing demand for advanced medical technologies, contributing to the Biopsy Guidance Systems market growth.

The development of artificial intelligence (AI) and machine learning (ML) technologies is expected to enhance the capabilities of Biopsy Guidance Systems, improving diagnostic accuracy and patient outcomes, and driving further expansion of the Biopsy Guidance Systems market size.

Challenges2 items

The Biopsy Guidance Systems market is highly competitive, with several established players competing for market share, making it challenging for new entrants to gain traction and impacting the overall growth forecast.

Ensuring the cybersecurity of Biopsy Guidance Systems is a significant challenge, as these systems often rely on connected technologies, posing a risk to patient data and requiring manufacturers to invest in robust security measures to protect the Biopsy Guidance Systems market.

Market Segmentation

Loading chart…

The Application segment of the Biopsy Guidance Systems market refers to the various medical specialties and procedures that utilize these systems. This segment is crucial in understanding the Biopsy Guidance Systems segmentation as it highlights the diverse uses of these systems across different medical disciplines. The application segment contributes significantly to the overall market size, with key areas including tumor diagnosis, cancer treatment, and tissue sampling.

The Types segment of the Biopsy Guidance Systems market encompasses the different types of guidance systems available, including subtypes such as ultrasound-guided, MRI-guided, and CT-guided systems. Each subtype has its unique characteristics, advantages, and limitations, catering to specific medical needs and preferences. Understanding the types segment is vital for market taxonomy as it provides insights into the technological advancements and innovations driving the growth of the Biopsy Guidance Systems market.

Biopsy Guidance Systems Segmentation Breakdown10 items

Application

Hospitals

Specialty Clinics

Diagnostic Centers

Research and Academic Institutes

Others

Types

Stereotactic Guided Biopsy

Ultrasound Guided Biopsy

MRI Guided Biopsy

Regional Insights

Loading chart…

The Biopsy Guidance Systems market growth is anticipated to vary across regions, with North America being the largest region, accounting for approximately 40% of the global market share. The Asia Pacific region is expected to be the fastest-growing region, driven by increasing adoption of advanced medical technologies, favorable policies, and significant investments in healthcare infrastructure.

Key drivers for each region include: for North America, high ecosystem maturity, established healthcare infrastructure, and significant investments in research and development; for Europe, favorable policies, increasing adoption of minimally invasive procedures, and a large patient population; for Asia Pacific, rising demographics, growing healthcare expenditure, and increasing adoption of advanced medical technologies; for Latin America, growing demand for biopsy procedures, improving healthcare infrastructure, and increasing investments in medical technologies; and for Middle East & Africa, rising demographics, growing healthcare expenditure, and increasing adoption of advanced medical technologies.

The regional forecast indicates that the Asia Pacific region will drive the Biopsy Guidance Systems market growth in the coming years, with a significant increase in adoption of advanced medical technologies and growing investments in healthcare infrastructure. The North America region will continue to dominate the market, driven by high ecosystem maturity and significant investments in research and development.

Competitive Landscape

The Biopsy Guidance Systems market is moderately consolidated, with a mix of global players and local companies competing on factors such as pricing, distribution, product innovation, certifications, and regulatory approvals. The Biopsy Guidance Systems competitive landscape is driven by the ability of key players to balance these levers and adapt to changing market conditions. Global companies tend to have an edge in terms of product portfolio and distribution networks, while local players focus on regional expertise and customization.

Companies in this market employ various strategies to differentiate themselves, including mergers and acquisitions, partnerships, product launches, and research and development. However, they face challenges such as margin pressure, compliance costs, and commoditization, which can erode their competitive advantages. To stay ahead, companies must focus on technological innovation, service model excellence, channel strength, and cost advantages. The following companies are notable for their strategic focus:

BD: regional expansion

Hologic, Inc.: innovation pipeline

Devicor Medical Products, Inc.: premium pricing

B. Braun Melsungen AG: local manufacturing

Boston Scientific Corporation: OEM tie-ups

Planmed Oy: vertical integration

Key Biopsy Guidance Systems Companies6 items

Hologic, Inc.

Devicor Medical Products, Inc.

B. Braun Melsungen AG

Boston Scientific Corporation

Planmed Oy

Market Ecosystem

The Biopsy Guidance Systems ecosystem encompasses a complex network of participants, spanning upstream technology providers and suppliers to downstream end users. This ecosystem can be broadly segmented into three main stages: upstream, where raw materials and components are sourced; midstream, where systems are manufactured and integrated; and downstream, where products are distributed and used by end users. Understanding the interactions and interdependencies within this ecosystem is crucial for conducting a comprehensive value chain analysis.

Raw material/component suppliers — providing key components

OEMs / manufacturers — designing and building systems

System integrators / EPCs — integrating systems with other medical equipment

Distributors / channel partners — delivering products to end users

Service providers / after-sales — offering maintenance and support services

End users / buyers — utilizing biopsy guidance systems in medical procedures

Regulators/standards bodies — establishing guidelines and approvals for system use

Within the Biopsy Guidance Systems ecosystem, control points are primarily held by regulators and standards bodies, as their approvals and guidelines significantly influence adoption rates. Dependency risks arise from input constraints, such as the availability of key components, and from regulatory approvals, which can delay market entry. Switching costs for end users can be high due to the need for interoperability with existing medical equipment and the requirement for specialized training. The ecosystem's structure and dynamics can vary by region, with different regulatory environments and market conditions affecting the flow of value and the interactions among participants.

Recent Industry Insights

The Biopsy Guidance Systems industry trends have witnessed significant developments over the last 12-18 months, driven by advancements in technology and strategic collaborations. Notable partnerships have been formed between leading medical device manufacturers and healthcare providers, aiming to enhance the accuracy and efficiency of biopsy procedures. Recent mergers and acquisitions have also contributed to the growth of the market, enabling companies to expand their product portfolios and strengthen their market presence.

Furthermore, the launch of innovative product lines and technologies has improved the diagnostic capabilities of biopsy guidance systems, catering to the increasing demand for minimally invasive procedures. Regulatory changes have also played a crucial role in shaping the industry, with a focus on ensuring patient safety and product efficacy. As a result, the Biopsy Guidance Systems industry is expected to continue its upward trajectory, driven by shifting consumer preferences, funding rounds, and expansions in the healthcare sector.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the Biopsy Guidance Systems market outlook. The market attractiveness is moderate, driven by the increasing prevalence of chronic diseases and the need for accurate diagnosis. The competitive intensity is high, with key players investing heavily in research and development to improve product offerings.

The long-term outlook for the Biopsy Guidance Systems market is positive, with opportunities for growth in emerging markets and the development of new technologies. However, the market is not without risks, including intense competition and regulatory challenges. The innovation landscape is characterized by advancements in imaging technologies and the integration of artificial intelligence. The demand-supply balance is expected to be stable, with key risk factors including supply chain disruptions and fluctuations in demand.

12 items

1. Executive Summary

2. Biopsy Guidance Systems Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Biopsy Guidance Systems Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Biopsy Guidance Systems Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Biopsy Guidance Systems Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Biopsy Guidance Systems Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Biopsy Guidance Systems Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Biopsy Guidance Systems Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Biopsy Guidance Systems Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Biopsy Guidance Systems Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Biopsy Guidance Systems Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Biopsy Guidance Systems Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Biopsy Guidance Systems Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Biopsy Guidance Systems Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Biopsy Guidance Systems Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Biopsy Guidance Systems Market Competition by Key Manufacturers

9.1. Global Biopsy Guidance Systems Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Biopsy Guidance Systems: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. BD

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Hologic, Inc.

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Devicor Medical Products, Inc.

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. B. Braun Melsungen AG

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Boston Scientific Corporation

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Planmed Oy

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Biopsy Guidance Systems Market

Figure 4: Global Biopsy Guidance Systems Market: Drivers

Figure 5: Global Biopsy Guidance Systems Market: Challenges

Figure 6: Global Biopsy Guidance Systems Market: Trends

Figure 7: Global Biopsy Guidance Systems Market: Opportunity

Figure 8: Global Biopsy Guidance Systems Market: Restraint

Figure 9: Global Biopsy Guidance Systems Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Biopsy Guidance Systems Market Value (USD Million) By Region

Figure 19: Global Biopsy Guidance Systems Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Biopsy Guidance Systems Market Value (USD Million) By Region

Figure 27: Global Biopsy Guidance Systems Market Share (%) By: Regions (2032)

Figure 28: Global Biopsy Guidance Systems Market Volume (K) By Region

Figure 29: Global Biopsy Guidance Systems Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Biopsy Guidance Systems Market Value (USD Million) By Region

Figure 37: Global Biopsy Guidance Systems Market Share (%) By: Regions (2032)

Figure 38: Global Biopsy Guidance Systems Market Volume (K) By Region

Figure 39: Global Biopsy Guidance Systems Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

107 items

Table 1: Market Segmentation Analysis

Table 2: Global Biopsy Guidance Systems Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Biopsy Guidance Systems Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Biopsy Guidance Systems Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Biopsy Guidance Systems Market Value (USD Million) By Region

Table 14: Global Biopsy Guidance Systems Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Biopsy Guidance Systems Market Volume (K) By Region

Table 31: Global Biopsy Guidance Systems Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Biopsy Guidance Systems Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Biopsy Guidance Systems Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Biopsy Guidance Systems Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: BD Basic Information And Sales Area

Table 52: BD. Products Portfolio

Table 53: Hologic, Inc. Basic Information And Sales Area

Table 54: Hologic, Inc.. Products Portfolio

Table 55: Devicor Medical Products, Inc. Basic Information And Sales Area

Table 56: Devicor Medical Products, Inc.. Products Portfolio

Table 57: B. Braun Melsungen AG Basic Information And Sales Area

Table 58: B. Braun Melsungen AG. Products Portfolio

Table 59: Boston Scientific Corporation Basic Information And Sales Area

Table 60: Boston Scientific Corporation. Products Portfolio

Table 61: Planmed Oy Basic Information And Sales Area

Table 62: Planmed Oy. Products Portfolio

Table 63: Global Market Value (USD Million) (2025-2032) By Application

Table 64: Global Market Share (%) By Application (2032)

Table 65: Global Market Value (USD Million) (2025-2032) By Types

Table 66: Global Market Share (%) By Types (2032)

Table 67: Global Market Volume (K) (2025-2032) By Application

Table 68: Global Market Share (%) By Application (2032)

Table 69: Global Market Volume (K) (2025-2032) By Types

Table 70: Global Market Share (%) By Types (2032)

Table 71: Global Biopsy Guidance Systems Market Value (USD Million) By Region

Table 72: Global Biopsy Guidance Systems Market Share (%) By Region (2025-2032)

Table 73: North America Market Value (USD Million) (2025-2032) By Country

Table 74: North America Market Value (USD Million) (2025-2032) By Application

Table 75: North America Market Value (USD Million) (2025-2032) By Types

Table 76: Europe Market Value (USD Million) (2025-2032) By Country

Table 77: Europe Market Value (USD Million) (2025-2032) By Application

Table 78: Europe Market Value (USD Million) (2025-2032) By Types

Table 79: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 80: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 81: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 82: South America Market Value (USD Million) (2025-2032) By Country

Table 83: South America Market Value (USD Million) (2025-2032) By Application

Table 84: South America Market Value (USD Million) (2025-2032) By Types

Table 85: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 86: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 87: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 88: Global Biopsy Guidance Systems Market Volume (K) By Region

Table 89: Global Biopsy Guidance Systems Market Share (%) By Region (2025-2032)

Table 90: North America Market Volume (K) (2025-2032) By Country

Table 91: North America Market Volume (K) (2025-2032) By Application

Table 92: North America Market Volume (K) (2025-2032) By Types

Table 93: Europe Market Volume (K) (2025-2032) By Country

Table 94: Europe Market Volume (K) (2025-2032) By Application

Table 95: Europe Market Volume (K) (2025-2032) By Types

Table 96: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 97: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 98: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 99: South America Market Volume (K) (2025-2032) By Country

Table 100: South America Market Volume (K) (2025-2032) By Application

Table 101: South America Market Volume (K) (2025-2032) By Types

Table 102: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 103: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 104: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 105: Research Programs/Design For This Report

Table 106: Key Data Information From Secondary Sources

Table 107: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Biopsy Guidance Systems Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.19 billion
Growth rate	CAGR of 7.8% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	BD; Hologic, Inc.; Devicor Medical Products, Inc.; B. Braun Melsungen AG; Boston Scientific Corporation; Planmed Oy
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options